JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
173 hedge funds and large institutions have $2.28B invested in Juno Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 50
31% less call options, than puts
Call options by funds: $31.1M | Put options by funds: $45.3M
Holders
173
Holding in Top 10
6
Calls
$31.1M
Puts
$45.3M
Top Buyers
| 1 | +$66.3M | |
| 2 | +$27.4M | |
| 3 | +$22.7M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$19.8M |
| 5 |
Morgan Stanley
New York
|
+$17.6M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$9.1M | |
| 3 | -$7.53M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.45M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.94M |